WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 232
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 292

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 24'895  24'763  24'631  24'501  24'372  22'840  20'194  17'372 
Births 358  356  354  353  353  409  421  349 
Surviving infants 350  348  346  345  344  391  407  338 
Pop. less than 5 years 1'710  1'690  1'691  1'719  1'745  1'983  1'950  1'586 
Pop. less than 15 years 5'400  5'435  5'484  5'553  5'621  5'943  5'406  6'302 
Female 15-49 years 6'676  6'645  6'611  6'582  6'568  6'073  5'750  4'619 

Number of reported case

(Click for retrospective incidence data for Democratic People's Republic of Korea (the))
Diphtheria 18 
Japanese encephalitis 10 
Measles
Mumps 11  66  18 
Pertussis 13  304  58 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 537 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Democratic People's Republic of Korea (the))
Vaccine year result method % card seen                                                
BCG 2007  97  EPI   100  98  98  98  98  98  82  99  50 
DTP1 2007  94  EPI   100  94  97  95  94  94  82 
DTP3 2007  92  EPI   100  93  96  94  93  93  80  98  50 
HepB_BD          99  99  99  99  99 
HepB3 2007  92  EPI   100  96  94  93  93  30 
Hib3          96 
JapEnc         
MCV 2007  99  EPI   100  99  99  99  99  98  92  98  29 
MCV2          99  99  99  99  98 
PCV1         
PCV3         
Pol3 2007  99  EPI   100  99  99  99  99  98  98  99  50 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  74  MICS   99  99  99  99  98  97  84  98 
PAB         
VAD1          99  100  100  100  99  100 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Democratic People's Republic of Korea (the))
BCG 98  98  98  98  98  78  99  50 
DTP1 94  97  95  94  94  61  98  74 
DTP3 93  96  94  93  93  56  98  50 
HepB3 93  94  92  92  92 
HepB_BD 99  99  99  99  98 
Hib3 32 
MCV 99  99  99  99  98  78  98  29 
MCV2 99  99  99  99  98 
PAB 93  93  93  91  91  81  90 
PCV3
Pol3 99  99  99  99  98  93  99  50 
Rota_last

Number of districts in the country 209  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
Measles 9, 15 months; Yes
OPV 6, 10, 14 weeks; Yes
Td 3, 4 months; Yes
VitaminA 6-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 209  208          206 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No       

System performance

Total Nº districts in country number 209  208  208  208  208  210  206 
Nº districts with DTP3 coverage >=80% number 209  208  208  208  208  210 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 209  208  208  208  208  210   
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%     21  10  NA 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.